Compare Exelixis Inc. Common Stock (EXEL) vs Guardant Health Inc. Common Stock (GH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Guardant Health Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.11 (market cap $14.62B), while Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.22B). The key difference: Guardant Health Inc. Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Guardant Health Inc. Common Stock for 0 Days on average.
| EXEL | GH | |
|---|---|---|
Market Cap | $14.62B | $22.22B |
Volume | 2,684,957 | 1,589,453 |
Sector | Health | Health |
52-Week High | $59.13 | $187.22 |
52-Week Low | $34.54 | $61.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $22.86B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →
